HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Jovan Expresses Its Individuality With Contemporary Marketing Approach

This article was originally published in The Rose Sheet

Executive Summary

Coty will back the introduction of Jovan Individuality, a four-scent fragrance oil line, with hip, modern advertising and promotional vehicles intended to attract a younger audience to the brand.

You may also be interested in...



Calvin Klein Unleashes Truth In Fragrance

Truth Calvin Klein women's scent is anchored in two recent fragrance trends: customization and sensuality. Slated to bow in August, the "lush, sensual" scent brings a "new olfactive family" to the fragrance market compared to traditional floral and oriental scents, Calvin Klein Cosmetics said.

Calvin Klein Unleashes Truth In Fragrance

Truth Calvin Klein women's scent is anchored in two recent fragrance trends: customization and sensuality. Slated to bow in August, the "lush, sensual" scent brings a "new olfactive family" to the fragrance market compared to traditional floral and oriental scents, Calvin Klein Cosmetics said.

Coty Jovan Body Tonics To Lighten Up Traditional Fragrance Offerings

The launch of Jovan Body Tonics is intended to "invigorate" the men's mass arena as Coty continues to capitalize on the growing alternative fragrance market, the company said. The nine-SKU line, designed to combine fragrance with function, will fill a "sporty" niche in the men's market with lighter fragrance items for the "next generation" of Jovan customers, the firm noted.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007678

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel